Publications Disparities in cardiovascular disease mortality after breast cancer treatment: methodological considerations using real-world data December 7, 2021 Calip, GS, Brown-Wade, N, Guadamuz, JS, Wang, X, Miksad, RA, Whitaker, K. Cancer. . https://acsjournals.onlinelibrary.wiley.com/doi/full/10.1002/cncr.34045 Authors:Calip, GS, Brown-Wade, N, Guadamuz, JS, Wang, X, Miksad, RA, Whitaker, K Sources:Cancer Read the research SharePosted inHealth equityBreast cancer More publicationsNovember 2026Unmasking hidden risk: clinical and real-world factors associated with functional high-risk multiple myeloma and their impact on treatment and outcomes — a real-world evidence studyOctober 2026Real-world first-line treatment patterns in ARPI-experienced metastatic castration-resistant prostate cancer (mCRPC) by race/ethnicity and area-level socioeconomic status (SES) in the USOctober 2026Cross-country differences in real-world laboratory monitoring intensity and hepatotoxicity adverse event detection among initiators of CDK4/6 inhibitors for advanced breast cancer
November 2026Unmasking hidden risk: clinical and real-world factors associated with functional high-risk multiple myeloma and their impact on treatment and outcomes — a real-world evidence study
October 2026Real-world first-line treatment patterns in ARPI-experienced metastatic castration-resistant prostate cancer (mCRPC) by race/ethnicity and area-level socioeconomic status (SES) in the US
October 2026Cross-country differences in real-world laboratory monitoring intensity and hepatotoxicity adverse event detection among initiators of CDK4/6 inhibitors for advanced breast cancer